Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases - Wikidata - awgldk - TriplyDB

Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases

Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases

http://www.wikidata.org/entity/Q36918509

about

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer PPARs Link Early Life Nutritional Insults to Later Programmed Hypertension and Metabolic Syndrome Dual mode action of mangiferin in mouse liver under high fat diet Systematic Understanding of Mechanisms of a Chinese Herbal Formula in Treatment of Metabolic Syndrome by an Integrated Pharmacology Approach Allicin induces the upregulation of ABCA1 expression via PPARγ/LXRα signaling in THP-1 macrophage-derived foam cells Weight loss herbal intervention therapy (W-LHIT) a non-appetite suppressing natural product controls weight and lowers cholesterol and glucose levels in a murine model Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1 PPAR-alpha and PPAR-beta expression changes in the hippocampus of rats undergoing global cerebral ischemia/reperfusion due to PPAR-gamma status Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.Early pharmacological inhibition of angiotensin-I converting enzyme activity induces obesity in adulthood The Use of Green Leaf Membranes to Promote Appetite Control, Suppress Hedonic Hunger and Loose Body Weight.Activation of peroxisome proliferator-activated receptor γ ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.The 482Ser of PPARGC1A and 12Pro of PPARG2 Alleles Are Associated with Reduction of Metabolic Risk Factors Even Obesity in a Mexican-Mestizo Population Environmentally Relevant Dose of Bisphenol A Does Not Affect Lipid Metabolism and Has No Synergetic or Antagonistic Effects on Genistein's Beneficial Roles on Lipid Metabolism Donor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational Study Subcellular proteomic approach for identifying the signaling effectors of protein kinase C-β₂ under high glucose conditions in human umbilical vein endothelial cells PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states.A Recipe Composed of Chinese Herbal Active Components Regulates Hepatic Lipid Metabolism of NAFLD In Vivo and In Vitro.Oyster crude polysaccharides attenuates lipopolysaccharide-induced cytokines production and PPARγ expression in weanling piglets.Effects of a healthy Nordic diet on gene expression changes in peripheral blood mononuclear cells in response to an oral glucose tolerance test in subjects with metabolic syndrome: a SYSDIET sub-study.Nutrigenomic Functions of PPARs in Obesogenic Environments.Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions.Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway.Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.Inhibition of age-related cytokines production by ATGL: a mechanism linked to the anti-inflammatory effect of resveratrol.Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ.PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study.Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts.Obesity and genomics: role of technology in unraveling the complex genetic architecture of obesity.The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic β-cells, glycemic control and inflammation: In vitro and in vivo studies Impact of nutrition on pollutant toxicity: an update with new insights into epigenetic regulation.Thiazolidinediones Inhibit Mouse Osteoblastic MC3T3-E1 Cell Proliferation in Part Through the Wnt Signaling Pathway.Dietary essential α-linolenic acid and linoleic acid differentially modulate TNFα-induced NFκB activity in FADS2-deficient HEK-293 cells.Influence of the Periodontal Disease, the Most Prevalent Inflammatory Event, in Peroxisome Proliferator-Activated Receptors Linking Nutrition and Energy Metabolism.

P2860

Q24561401-47006D9E-D147-45CD-B097-017673BEA89F Q26745533-7147943E-E88E-4555-A448-09E685242D9F Q26747009-A1DA4AA1-EA5F-4191-8AF4-F4BF17A59E6A Q26764921-23EF704C-6865-44F9-94DE-45B39794FAD6 Q26771825-72CF6142-C452-48B7-BDB3-70C87CCD41E0 Q28540472-361E0426-6B3B-4F52-82D5-C4FE1C89795F Q28818589-71B90FAC-5381-4F3B-9C86-C2989FA6A368 Q33675106-91B5D069-2AE3-4DE7-90BD-10BB4F71BF0F Q34017884-D48E726A-987F-4B6C-899E-6F6A7C111CB7 Q34178976-37B09E29-8389-471A-B1DF-8E84102154CD Q34203838-0A6D118E-D77B-40AB-A751-647EC3202BD1 Q34511474-D9428CDB-CAC1-4E55-A664-2BF778019A3C Q34835301-94EBE9E9-D2FC-4DD5-AE97-A90505B5C227 Q35407199-D05EC4FB-704E-445F-84CD-114DC0D9D5AA Q35675981-D1C58B8C-6184-4FC5-AA2F-22A752F4F27E Q35803453-D4D1FEE1-211B-4052-8B1B-0FBA2699F791 Q35818043-103B2DE1-92E0-4758-A3A1-CD1C787EC4FC Q36015716-F7A20B73-E444-4745-B73D-341FABCD7080 Q36194349-42BA221F-7491-4D8D-AAF5-92A6F2A8F100 Q36224900-B79B5628-3CC7-4C5D-8B25-BD0B73937C2E Q36360452-AA5A5801-A3DA-4079-AE2B-8C726912F37C Q36668641-1B175A99-709D-4634-A7D7-4B44BDA97FB3 Q36724703-8BC748AF-500F-42A9-86B5-EE87C346F8FF Q36741143-09F83E17-6919-4A79-8C8C-26E713A4C253 Q36985027-9DA32516-D546-41EF-905F-09B6C86194BB Q37123153-8F46D4EB-B898-45E6-832F-91F74CCEEC5B Q37500797-AE0F384A-598C-400C-B89C-2BE17D5326C4 Q37578702-0141776F-384A-4CE9-8163-AADBEB59964C Q37611286-B3FDF0BC-FD53-4047-A51B-ACF10F4A1770 Q37686240-35C3AE14-3C9F-46FF-8461-64A314BDF116 Q37725562-0C0217C7-E0D5-423F-8E97-AD510FD08EF3 Q37737114-7BC81101-BDB6-4E1A-9659-B4AB812B8390 Q37737476-2D85B6D1-132E-433B-B135-B19A5FAB637D Q38157926-F4B9D1DB-0C8D-4CB6-A552-100C397907EF Q38357876-B97CD904-0D91-46A9-B7DC-896A3B0CA0BB Q38740027-5C62066A-3869-42DD-ADD1-05752A80A184 Q38771879-D0E6C141-40B9-46FB-A509-1B35A7FE9110 Q38901674-A3527B0D-A818-4F88-93C0-84423C82799C Q39104729-65F46D8D-314C-4EBA-82C4-45FED347DCC7 Q39415191-D9508208-4C67-44D7-B2F5-58ABF5320A30

P2860

Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases

http://www.wikidata.org/entity/Q36918509

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Peroxisome proliferator-activa ...... reatment of metabolic diseases

@en

type

label

Peroxisome proliferator-activa ...... reatment of metabolic diseases

@en

prefLabel

Peroxisome proliferator-activa ...... reatment of metabolic diseases

@en

P1433

Q36918509-DDF59B3C-9FBE-4FC4-8229-A2F1E6C1FB38

P1476

Q36918509-54C1C257-0A5A-4FCF-AF23-23F63665217D

P2093

Q36918509-782725D8-E75C-48C5-AF6F-1C670B959FBA

Q36918509-8B8AE392-06C3-4DAA-B886-74DED6F64B31

Q36918509-AB1C5FF5-CBAA-4A07-97CC-D6CF15F99F16

P275

Q36918509-1EC38F5E-96D2-43F0-B62D-0599D61BEBF5

P2860

Q36918509-039D108E-9703-4F96-B350-02F5F862D0A6

Q36918509-049A21A9-83DB-488F-881B-939056A74918

Q36918509-0876E15B-AB78-4CC9-AEFE-06F405D4F6B5

Q36918509-08C60751-A86C-4743-B896-F88153B8818F

Q36918509-0A7801CD-2CFD-4C51-8953-42830231B73D

Q36918509-0C39421E-BBB2-4DAB-968C-316D007E0543

Q36918509-0C581C6A-1419-405D-A581-5CACC884E177

Q36918509-0ED7E735-7839-4347-8167-C1DDF01D61DE

Q36918509-10822E82-AB9E-420E-970A-4E274D53610A

Q36918509-1091CE3C-BEA1-4B52-90E5-F10AD7524B42

P304

Q36918509-B87D1905-EBBF-498D-96A8-6F2245C7C09A

P31

Q36918509-BCBFC4F8-1566-4541-8F6A-11E263301990

P356

Q36918509-BB8DEC2D-3447-4361-805C-C71E74444D5C

P478

Q36918509-214394E3-B7CB-4FAA-9CAD-405185B07791

P50

Q36918509-7DA3EA69-8B7B-4D6C-905B-3C12AD57EFAF

P5008

Q36918509-4DEAF788-63B9-4863-A082-06C7D0FD86ED

P577

Q36918509-18EFE807-90D8-4F91-830E-49BA929EDCF9

P5875

Q36918509-45C4053A-FCDA-4843-9EB3-E50B8FA8CFDD

P698

Q36918509-9373F435-9CCD-44E9-8AE5-B9E2010FB779

P921

Q36918509-2D63BFB4-4B60-4893-B5EC-6B7C17AC8837

Q36918509-5ABFC1E6-498A-45EF-A62F-B75F61B2FB09

Q36918509-6868B1F5-A887-4226-BFA2-FFBD32941006

P932

Q36918509-10F70191-06EC-4287-982C-413F0FE09009

P356

P1433

Mediators of Inflammation

P1476

Peroxisome proliferator-activa ...... reatment of metabolic diseases

@en

P2093

Fernando Delgado-Lopez

http://www.w3.org/2001/XMLSchema#string

Francisco A Monsalve

http://www.w3.org/2001/XMLSchema#string

Rodrigo Moore-Carrasco

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Insulin signalling and the regulation of glucose and lipid metabolism

Direct demonstration of involvement of protein kinase Calpha in the Ca2+-induced platelet aggregation

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes

P304

549627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/549627

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Radha D Pyarasani

P5008

P577

2013-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239948624

http://www.w3.org/2001/XMLSchema#string

P698

23781121

http://www.w3.org/2001/XMLSchema#string

P921

intracellular receptor

transcription factor

metabolic syndrome

P932

3678499

http://www.w3.org/2001/XMLSchema#string